PubMed · 2010 · 20 citations · 29 references
MedicineCardiologyPharmacologyCardiovascular PharmacotherapyClinical CardiologyInterventional CardiologyAtrial FibrillationCardiac BiomarkersCardiac Risk AssessmentCardiovascular DiseaseCardiovascular PathophysiologyHeart FailureAtrial Fibrillation AssessmentAtrial Fibrillation BiomarkersAtrial Fibrillation PathophysiologyB-type Natriuretic PeptidesBiomarkers Of Arrhythmia RiskElectrical CardioversionRhythm Control TherapyTreatment Response Biomarkers
BACKGROUND AND OBJECTIVE: Atrial fibrillation (AF) is the most common arrhythmia in the medical practice, it is associated with an increased total and cardiovascular mortality, as well as cardiovascular morbidity, including stroke and heart failure. AF is encountered in different medical specialties including cardiology, family medicine and emergency medicine as well. Treatment goal is to minimize stroke risk but also taking into account the quality of life. Therefore rate or a rhythm control strategies must be carefully selected. This review focuses on natriuretic polypeptides (NPs) as potential useful markers in AF patients management. EVIDENCE AND INFORMATION SOURCES: Pubmed was searched for natriuretic peptides and atrial fibrillation. Pertinent abstracts were reviewed by the Authors and the articles fully evaluated when considered pertinent. STATE OF THE ART: NP biology and physiology is described and general application in heart failure outlined. With regard to AF, the role of NP as predictor of cardioversion is reviewed and discussed. Patients eligible for rhythm control not always respond to treatment. Classic markers for a suitable cardioversion, such an echocardiography, are not immediately available in most settings. NP might be a resource predicting cardioversion (or not) upon patient's presentation. PROSPECTIVES: Biomarkers, such NPs, might be used to predict treatment response other than in heart failure. CONCLUSIONS: In AF management, NT-ProBNP is a promising tool helping physicians to choose rhythm or rate control strategy.
29
Prevalence of Diagnosed Atrial Fibrillation in Adults
Alan S. Go, Elaine M. Hylek, Kathleen A. Phillips et al. · JAMA · 2001 · 6.2K citations
Incidence of and Risk Factors for Atrial Fibrillation in Older Adults
Bruce M. Psaty, Teri A. Manolio, Lewis H. Kuller et al. · Circulation · 1997 · 1.5K citations
Inflammation as a Risk Factor for Atrial Fibrillation
Ronnier J. Aviles, David O. Martin, Carolyn Apperson-Hansen et al. · Circulation · 2003 · 1.4K citations
Histological Substrate of Atrial Biopsies in Patients With Lone Atrial Fibrillation
Andrea Frustaci, Cristina Chimenti, Fulvio Bellocci et al. · Circulation · 1997 · 1.4K citations
Medicine, Cardiology, Pathology +8